知镜 Cognispect · 医学文献与研究工作台

[The auxiliary diagnostic value of combined indicators based on dihydrolipoamide S-acetyltransferase in early diabetic kidney disease].

Tao Y, Ren YP, Wang K, Liang YL, Hou QZ, Liu YX, Yi B, Huang KK.
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] · 2026-11-01 · PMID 43035303

文献摘要

This study investigates the diagnostic value of combined indicators based on dihydrolipoamide S-acetyltransferase (DLAT) in early diabetic kidney disease (eDKD). This was a single-center, cross-sectional, observational clinical study. A total of 100 DKD patients admitted to Xiangya Hospital of Central South University from November 2024 to January 2025 were enrolled. According to the urinary albumin-to-creatinine ratio (UACR), they were divided into the eDKD group (30 mg/g≤UACR 1c ), estimated glomerular filtration rate (eGFR), triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), blood urea nitrogen (BUN), serum creatinine (Scr), uric acid (UA), kidney injury molecule-1 (KIM-1), DLAT, UACR, microalbumin (UmALB), iron ion (Fe²⁺), copper ion (Cu²⁺), zinc ion (Zn²⁺), copper-zinc ratio (Cu/Zn), and urinary creatinine (Ucr) levels, were compared among the three groups. Spearman correlation analysis was used to analyze the correlations of DLAT and KIM-1 with other factors. Multivariable logistic regression analysis was performed to identify indicators with significant differences among the three groups. Receiver operating characteristic curve (ROC) analysis was employed to evaluate the diagnostic performance of DLAT in combination with other indicators for diabetic kidney disease (DKD), specifically for eDKD. The results showed that statistically significant differences were observed between the T2DM group and the DKD group in the levels of serum eGFR ( Z =4.403, P 0.001), BUN ( Z =4.350, P Z =4.577, P t =3.894, P Z =7.379, P Z =8.409, P Z =10.827, P Z =10.164, P Z =3.580, P Z =3.397, P Z =3.919, P Z =2.302, P Z =2.862, P Z= 6.623, P Z= 8.632, P r =0.482, P r =-0.184, P r =-0.145, P r =-0.43, P r =0.158, P r =0.176, P OR =1.343, 95% CI: 1.217-1.481, P OR =4.097, 95% CI :1.095-15.331, P OR =0.802, 95% CI: 0.748-0.860, P <0.001) were independent factors associated with the presence of DKD in T2DM patients. KIM-1 and Cu/Zn were positively associated with the risk of DKD, whereas DLAT was negatively associated. ROC curve analysis indicated that the AUC for the combined diagnosis of DKD using KIM-1, DLAT, and Cu/Zn was 0.955, with a sensitivity of 87.8% and a specificity of 96.5%. For the diagnosis of eDKD, the combined application yielded an AUC of 0.953, with a sensitivity of 90% and a specificity of 96.5%. In conclusion,the non-invasive combined detection of blood biomarkers DLAT, KIM-1, and the Cu/Zn ratio holds significant clinical value for the diagnosis of eDKD, as it facilitates the identification of the critical therapeutic window, enabling early intervention to effectively retard disease progression.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。